Insights from 2024 ASCO® GI Annual Meeting
G

ASCO® GI 2024 Insights: "PROOF 301 Trial - Oral FGFR Inhibitor Infigratinib vs. Gemcitabine + Cisplatin in Patients With Advanced Cholangiocarcinoma With an FGFR2 Gene Fusion/Rearrangement"

By Insights from 2024 ASCO® GI Annual Meeting FEATURING Ghassan Abou-Alfa
By Insights from 2024 ASCO® GI Annual Meeting FEATURING Ghassan Abou-Alfa
172 views
January 31, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

21:24
Exelixis

Hypothetical Patient Case: Hepatocellular Carcinoma with Progression…

Feat. J. Gutierrez, J. Strauss

Featured Video

18:17
Exelixis

Treatment Decisions When Initiating a Tyrosine Kinase Inhibitor and …

Feat. K. Hanna, J. Strauss

Recommended

17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

·

7 months ago
57:44

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

5.1K views

·

1 year ago
27:04

Cancer Screening Molecular Tools

Fengting Yan

2.5K views

·

11 months ago
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views

·

7 months ago
22:55

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

3.1K views

·

1 year ago
27:37

ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates

ASCO GI 2023 Conference Coverage

N. Uboha, A. Turk, K. Spencer, M. Cecchini

4.1K views

·

1 year ago
22:33

Oligometastatic Colon Cancer to Liver: Case Presentation and Panel D…

Integrity CE

V. Lee, R. Kumar, N. Bhagat, E. Winslow

369 views

·

7 months ago
07:27

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

2.0K views

·

1 year ago
06:47

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

2.1K views

·

1 year ago
28:25

Extensive, Liver-Only Metastases From Colon Cancer: Case Presentatio…

Integrity CE

V. Lee, E. Christenson, N. Bhagat, E. Winslow

252 views

·

7 months ago
16:40

Year in Review: Hepatobiliary Cancers

Moffitt Cancer Center

R. Kim, T. Biachi

604 views

·

10 months ago
13:47

ASCO® 2023 Insights: "Expanding the Benefit - Dabrafenib/Trametinib …

Insights from 2023 ASCO® Annual Meeting

V. Subbiah

1.2K views

·

1 year ago
06:03

2024 Updates on Targeted Approaches for GI Cancers and New Data in N…

Total Health

A. Grothey

246 views

·

8 months ago
09:03

Combined Hepatocellular-Cholangiocarcinoma: Diagnosis and Management

Integrity CE

J. Birkness-Gartman

261 views

·

7 months ago
09:13

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

230 views

·

5 months ago
08:24

GI Oncology Year in Review: Hepatobiliary Cancers

Yale Cancer Center

P. Kunz

293 views

·

8 months ago
12:04

Pemigatinib in Cholangiocarcinoma: Targeting FGFR2 Fusions

Arndt Vogel

1.3K views

·

1 year ago
15:24

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Horizon CME

A. Scott

201 views

·

5 months ago
14:54

ESMO 2023 Summary: "HCC and Cholangiocarcinoma Mini Orals Highlights"

Insights from 2023 ESMO Annual Meeting

L. Rimassa

435 views

·

1 year ago
14:33

Personalized Medicine and Targeted Agents for Biliary Tract Cancer

Insights from 2023 ESMO Annual Meeting

L. Rimassa

461 views

·

1 year ago
AUTOPLAY